Retatrutide Peptide for Weight Loss Research | LY-3437943 CAS 2381089-83-2

Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide (LY-3437943) is a novel glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP-1)/glucagon (GCG) triple receptor agonist for research purposes. This innovative peptide demonstrates significant potential in metabolic regulation studies due to its unique multi-target mechanism of action.

The compound appears as a white powder with 99% purity, supplied in sterile vials for laboratory use. Researchers utilize Retatrutide in studies involving weight management, metabolic improvement, and blood sugar control mechanisms. Its triple agonist properties may offer synergistic effects compared to single-target GLP-1 agonists.

For research applications, Retatrutide may be valuable in studying:

- Appetite regulation and satiety mechanisms

- Metabolic syndrome pathways

- Glucose homeostasis

- Potential weight management approaches

- Multi-hormonal signaling interactions

The product requires proper storage at 2-8°C in a dark, dry environment to maintain stability. Researchers should handle all peptides using appropriate laboratory safety protocols.